(Q35554180)

8 August 2017

Prognostic factors for remission in early rheumatoid arthritis: a multiparameter prospective study (English)

1 reference

8 August 2017

1 reference

Gossec L

1

1 reference

8 August 2017

Dougados M

2

1 reference

8 August 2017

Goupille P

3

1 reference

8 August 2017

Cantagrel A

4

1 reference

8 August 2017

Sibilia J

5

1 reference

8 August 2017

Meyer O

6

1 reference

8 August 2017

Sany J

7

1 reference

8 August 2017

Daurès JP

8

1 reference

8 August 2017

Combe B

9

1 reference

8 August 2017

language of work or name

English

0 references

publication date

1 June 2004

1 reference

Annals of the Rheumatic Diseases

8 August 2017

1 reference

8 August 2017

63

1 reference

8 August 2017

6

1 reference

8 August 2017

675-680

1 reference

Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage

8 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755028

Delay to institution of therapy and induction of remission using single-drug or combination-disease-modifying antirheumatic drug therapy in early rheumatoid arthritis.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755028

Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755028

Combination therapy in early rheumatoid arthritis: a randomised, controlled, double blind 52 week clinical trial of sulphasalazine and methotrexate compared with the single components

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755028

Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo trial group

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755028

Anti-heat shock protein 70 kDa and 90 kDa antibodies in serum of patients with rheumatoid arthritis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755028

A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755028

Natural remission in inflammatory polyarthritis: issues of definition and prediction.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755028

Rheumatoid arthritis: pathogenesis and early recognition

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755028

Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755028

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755028

Long-term outcome of treating rheumatoid arthritis: results after 20 years

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755028

Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755028

Influence of HLA polymorphism on persistent remission in rheumatoid arthritis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755028

Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. European Leflunomide Study Group.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755028

Development of a disease activity score based on judgment in clinical practice by rheumatologists.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755028

Prognostic factors for radiographic damage in early rheumatoid arthritis: a multiparameter prospective study

26 September 2018

1 reference

12 December 2020

Functional disability in relation to radiological damage and disease activity in patients with rheumatoid arthritis in remission

1 reference

12 December 2020

Measurement of patient outcome in arthritis

1 reference

12 December 2020

Preliminary criteria for clinical remission in rheumatoid arthritis

1 reference

12 December 2020

Prognosis of inflammatory joint diseases. A three-year follow-up study

1 reference

12 December 2020

[Remission of rheumatoid arthritis. Apropos of 32 case reports]

1 reference

12 December 2020

Evaluation of the American Rheumatism Association preliminary criteria for remission in rheumatoid arthritis: a prospective study

1 reference

12 December 2020

Early rheumatoid arthritis--onset, course, and outcome over 2 years

1 reference

12 December 2020

Association of HLA-DR4 with a more progressive disease course in patients with rheumatoid arthritis. Results of a followup study

1 reference

12 December 2020

Anti-RA 33 antinuclear autoantibody in rheumatoid arthritis and mixed connective tissue disease: comparison with antikeratin and antiperinuclear antibodies

1 reference

12 December 2020

The prognosis of rheumatoid arthritis and undifferentiated polyarthritis syndrome in the clinic: a study of 1141 patients

1 reference

12 December 2020

Genetic typing of patients with inflammatory arthritis at presentation can be used to predict outcome

1 reference

12 December 2020

Prognostic factors in rheumatoid arthritis. Comparative study of two subsets of patients according to severity of articular damage

1 reference

12 December 2020

Outcome in patients with early rheumatoid arthritis treated according to the "sawtooth" strategy

1 reference

12 December 2020

Remission in a prospective study of patients with rheumatoid arthritis. American Rheumatism Association preliminary remission criteria in relation to the disease activity score

1 reference

12 December 2020

Preliminary core set of domains and reporting requirements for longitudinal observational studies in rheumatology

1 reference

12 December 2020

Clinical course and remission rate in patients with early rheumatoid arthritis: relationship to outcome after 5 years

1 reference

12 December 2020

Identifiers

DOI

10.1136/ARD.2003.010611

1 reference

8 August 2017

1 reference

8 August 2017

1 reference